Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Crowther

Showing results (11-20 of 286) with videos related to

Pageof 29
Sort By:
ACP Journal Club|March 6, 2007
An abnormal D-dimer test result indicated that anticoagulation should be continuedMark Crowther
Journal of Thrombosis and Thrombolysis|January 29, 2011
Practical issues with vitamin K antagonists: elevated INRs, low time-in-therapeutic range, and warfarin failureAndrea Lee, Mark Crowther
The New England Journal of Medicine|May 4, 2022
Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid ArthritisKarim Ladak, Mark Crowther
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 26, 2008
Erythropoietin-stimulating agents: ongoing concerns with safetyMark Crowther, Ghazala Radwi
Current Opinion in Pulmonary Medicine|October 18, 2007
Low molecular weight heparin and bleeding in patients with chronic renal failureMark Crowther, Wendy Lim
The New England Journal of Medicine|September 7, 2007
Targeting anemia with erythropoietin during critical illnessDeborah Cook, Mark Crowther
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|November 3, 2005
Anticoagulants and gastrointestinal bleedingMark Crowther, Paul Adams
Journal of Thrombosis and Thrombolysis|May 10, 2013
Reversal of target-specific oral anticoagulantsScott Kaatz, Mark Crowther
Polskie Archiwum Medycyny Wewnetrznej|December 24, 2016
2015 in hematology and thromboembolism. Dr. Mark Crowther in an interview with Dr. Roman Jaeschke: part 1Mark Crowther, Roman Jaeschke
Hematology. American Society of Hematology. Education Program|December 4, 2016
Thrombosis and anticoagulation in the setting of renal or liver diseaseChristine Ribic, Mark Crowther
Pageof 29

Showing results (11-20 of 286) with videos related to

Sort By:
Pageof 29
ACP Journal Club|March 6, 2007
An abnormal D-dimer test result indicated that anticoagulation should be continuedMark Crowther
Journal of Thrombosis and Thrombolysis|January 29, 2011
Practical issues with vitamin K antagonists: elevated INRs, low time-in-therapeutic range, and warfarin failureAndrea Lee, Mark Crowther
The New England Journal of Medicine|May 4, 2022
Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid ArthritisKarim Ladak, Mark Crowther
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 26, 2008
Erythropoietin-stimulating agents: ongoing concerns with safetyMark Crowther, Ghazala Radwi
Current Opinion in Pulmonary Medicine|October 18, 2007
Low molecular weight heparin and bleeding in patients with chronic renal failureMark Crowther, Wendy Lim
The New England Journal of Medicine|September 7, 2007
Targeting anemia with erythropoietin during critical illnessDeborah Cook, Mark Crowther
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|November 3, 2005
Anticoagulants and gastrointestinal bleedingMark Crowther, Paul Adams
Journal of Thrombosis and Thrombolysis|May 10, 2013
Reversal of target-specific oral anticoagulantsScott Kaatz, Mark Crowther
Polskie Archiwum Medycyny Wewnetrznej|December 24, 2016
2015 in hematology and thromboembolism. Dr. Mark Crowther in an interview with Dr. Roman Jaeschke: part 1Mark Crowther, Roman Jaeschke
Hematology. American Society of Hematology. Education Program|December 4, 2016
Thrombosis and anticoagulation in the setting of renal or liver diseaseChristine Ribic, Mark Crowther
Pageof 29